# Leadership, Planning, and Evaluation

> **NIH NIH P30** · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2022 · $505,427

## Abstract

LEADERSHIP, PLANNING, AND EVALUATION: PROJECT SUMMARY
The vision of the Herbert Irving Comprehensive Cancer Center (HICCC) is that discoveries here will end cancer
everywhere. This is achieved through a dynamic, multi-pronged mission: (1) foster discovery science, (2)
translate discovery science into innovative clinical trials and interdisciplinary clinical care, and (3) promote
bidirectional community outreach and engagement, all of which is promulgated through a Strategic Plan. The
goals of Leadership, Planning, and Evaluation (LPE) are to create and sustain this vision by nurturing an
innovative and nimble leadership team, buttressed by internal and external advisory groups, and inclusion of the
HICCC membership for the identification and prioritization of new opportunities. The HICCC furthermore charges
its leadership and advisory bodies to develop and maintain the Strategic Plan, which interdigitates with the
institutional Strategic Plan.
Leading the HICCC’s leadership, planning and evaluation activities is the Director, Anil K. Rustgi, MD, a
nationally known translational researcher who was recruited last year from the University of Pennsylvania’s
Abramson Cancer Center. Rustgi is supported by a highly experienced and cohesive team of Senior Leadership
that includes a Deputy Director and six Associate Directors. Together, this team comprises the Senior Leadership
Team (SLT). The SLT actively engages Program Leaders and a core of internal advisors in strategy and decision
making through Cancer Center Leadership Team (CCLT) meetings, where strategic and operational matters are
discussed and recommendations made to the Center Director. A highly productive committee structure, which
includes an Internal Advisory Board (IAB), External Advisory Board (EAB), Community Advisory Board (CAB),
and Cancer Research Career Enhancement (CRCE) Committee, complements HICCC leadership and allows
for diverse perspectives to help shape and guide the future of the HICCC.
Under Rustgi, the HICCC has set forth a new vision, which will help realize the Cancer Center’s full potential
over the next project period and beyond. Concurrently, care was taken to ensure that the HICCC continuously
responds to the CCSG Summary Statement, changing expectations for NCI-designated Comprehensive Cancer
Centers, and ongoing feedback and guidance from the IAB, EAB, CAB, and others. All contributors have
enthusiastically endorsed the Strategic Plan, along with the initiatives that have been identified for the years
ahead. The current LPE, which is hallmarked by active listening, inclusion, and an unyielding commitment to
serving the community, has resulted in a time of unprecedented growth. This is evidenced throughout the
application in the accomplishments and plans for Research Programs, COE, Shared Resources, and CRCE,
including noteworthy accomplishments in translation by bringing HICCC discoveries into the clinic.

## Key facts

- **NIH application ID:** 10469558
- **Project number:** 5P30CA013696-47
- **Recipient organization:** COLUMBIA UNIVERSITY HEALTH SCIENCES
- **Principal Investigator:** Anil K Rustgi
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $505,427
- **Award type:** 5
- **Project period:** 1997-07-04 → 2025-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10469558

## Citation

> US National Institutes of Health, RePORTER application 10469558, Leadership, Planning, and Evaluation (5P30CA013696-47). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10469558. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*